Citadel Advisors’s Aethlon Medical AEMD Stock Holding History

Citadel Advisors’s Portfolio AEMD Stock Details AEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35.4K	Buy	+8,595	New	+$89K	﹤0.01%	13263
2025 Q4	–	Sell	-1,902	Closed	-$71.2K	–	12537
2025 Q3	$71.2K	Buy	+1,902	New	+$110K	﹤0.01%	12028
2025 Q2	–	Sell	-35	Closed	-$5.06K	–	12347
2025 Q1	$5.06K	Buy	+35	New	+$8.15K	﹤0.01%	13843
2022 Q4	–	Sell	-31	Closed	-$72K	–	14823
2022 Q3	$72K	Buy	+31	New	+$134K	﹤0.01%	11351
2022 Q1	–	Sell	-9	Closed	-$66K	–	13468
2021 Q4	$66K	Buy	+9	New	+$102K	﹤0.01%	13081
2021 Q2	–	Sell	-4	Closed	-$29K	–	13583
2021 Q1	$29K	Buy	+4	New	+$38.5K	﹤0.01%	13033
2019 Q4	–	Hold	0	–	-$2K	–	9039
2019 Q3	–	Sell	-1	Closed	-$17.3K	–	9080
2019 Q2	$30K	Buy	+1	New	+$33.5K	﹤0.01%	8872
2019 Q1	–	Hold	0	–	–	–	9047
2018 Q4	–	Hold	0	–	-$17K	–	9021
2018 Q3	–	Hold	0	–	–	–	9035
2017 Q4	–	Hold	0	–	-$19K	–	7915
2017 Q3	–	Hold	0	–	–	–	7365

Other funds holding AEMD

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SRL

Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors's AEMD Position: Q2 2026 in Review

Citadel Advisors opened a new position in Aethlon Medical (AEMD) in Q2 2026: 8,595 shares worth $35.4K. The stake represents ﹤0.01% of the portfolio and ranks #13263 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in AEMD as recently as Q3 2025.

Citadel Advisors first reported a position in AEMD in Q2 2019 and has held it in 7 quarters since. The position peaked at $72K in Q3 2022. 15 funds tracked by Wall St. Rank hold AEMD as of Q2 2026.

Citadel Advisors held 8,595 shares of Aethlon Medical worth $35.4K as of Q2 2026.
Aethlon Medical was a new Citadel Advisors position in Q2 2026.
Aethlon Medical made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13263 holding.
Citadel Advisors first reported a position in Aethlon Medical in Q2 2019 and has held it in 7 quarters since.
Citadel Advisors's Aethlon Medical position peaked at $72K in Q3 2022.
15 funds tracked by Wall St. Rank held Aethlon Medical as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.